Gynecologic Cancer News

Uterine microbial diversity appeared higher among Black women diagnosed with endometrial cancer compared with their white counterparts, according to study results.

Veliparib plus carboplatin/paclitaxel followed by veliparib maintenance showed smaller improvements in health-related quality of life measures from baseline compared with carboplatin/paclitaxel alone among patients with newly diagnosed stage III or IV ovarian cancer.

Subsequent chemotherapy showed less efficacy in BRCA 1 and 2-mutated, platinum-sensitive, recurrent epithelial ovarian cancer treated with maintenance olaparib compared with placebo, according to a presentation at ESMO Virtual Congress 2020.

Adding pazopanib to paclitaxel in patients with recurrent ovarian cancer progressing during bevacizumab maintenance therapy was not superior to paclitaxel alone, according to data presented at ESMO Virtual Congress 2020.

Global Cancer Institute has appointed two oncologists to serve as co-chief medical officers.

Quadrivalent HPV vaccination substantially reduced the risk for invasive cervical cancer among Swedish girls and women aged 10 to 30 years, according to results of a study published in The New England Journal of Medicine.

September is Gynecologic Cancer Awareness Month, an awareness campaign launched in 1999 by Foundation for Women’s Cancer.

Opioids are a potent pharmacologic option for managing recurrent pain experienced by cancer survivors.

Don Dizon, MD, is an innovator in oncology and an expert in social media. In this episode, we discuss the importance of authenticity and how platforms like Tik Tok have helped him engage with patients.

The European Society for Medical Oncology announced the recipients of this year’s ESMO Awards.